Cytori Therapeutics, Inc. Sells First U.S. StemSource(R) Cell Bank

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) has sold its first StemSource® Cell Bank in the United States. The StemSource® Cell Bank is a suite of products that offers patients a way to store their own adipose tissue, or the stem and regenerative cells naturally occurring within their own adipose tissue, in an automated, affordable and safe manner. This adipose tissue bank is expected to be installed during the next few months, making it the fourth StemSource® Cell Bank to be installed worldwide and the first in the United States.

MORE ON THIS TOPIC